Cargando…

Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment

SIMPLE SUMMARY: Renal cell carcinoma (RCC) cancer is among the ten most common malignancies, and frequently presents as metastatic disease (mRCC). For these patients, systemic treatment is in order, but mRCC is often highly heterogeneous, and resistant to conventional therapies, or acquires resistan...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Beijnum, Judy R., Weiss, Andrea, Berndsen, Robert H., Wong, Tse J., Reckman, Louise C., Piersma, Sander R., Zoetemelk, Marloes, de Haas, Richard, Dormond, Olivier, Bex, Axel, Henneman, Alexander A., Jimenez, Connie R., Griffioen, Arjan W., Nowak-Sliwinska, Patrycja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564658/ https://www.ncbi.nlm.nih.gov/pubmed/32967224 http://dx.doi.org/10.3390/cancers12092697

Ejemplares similares

Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance
por: Rausch, Magdalena, et al.
Publicado: (2020)

Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma
por: Zoetemelk, Marloes, et al.
Publicado: (2019)

A genomic screen for angiosuppressor genes in the tumor endothelium identifies a multifaceted angiostatic role for bromodomain containing 7 (BRD7)
por: van Beijnum, Judy R., et al.
Publicado: (2017)

Erratum to: miRNAs: micro-managers of anticancer combination therapies
por: van Beijnum, Judy R., et al.
Publicado: (2017)

miRNAs: micro-managers of anticancer combination therapies
por: van Beijnum, Judy R., et al.
Publicado: (2017)

Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2018)

Erratum: Berndsen, R.H., et al. Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib, Cancers 2019, 11, 1878
por: Berndsen, Robert H., et al.
Publicado: (2020)

Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
por: Berndsen, Robert H., et al.
Publicado: (2019)

Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2010)

Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment
por: Zoetemelk, Marloes, et al.
Publicado: (2020)

Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
por: Weiss, Andrea, et al.
Publicado: (2015)

Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization
por: Weiss, Andrea, et al.
Publicado: (2014)

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2012)

Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
por: Zoetemelk, Marloes, et al.
Publicado: (2020)

Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
por: Hany, Dina, et al.
Publicado: (2023)

Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets
por: Rausch, Magdalena, et al.
Publicado: (2021)

Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy
por: Weiss, Andrea, et al.
Publicado: (2015)

Apoptosis on the move
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2018)

Programmed cell death lives
por: Griffioen, Arjan W., et al.
Publicado: (2022)

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
por: van Beijnum, Judy R., et al.
Publicado: (2022)

Combination of ruthenium(II)-arene complex [Ru(η(6)-p-cymene)Cl(2)(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity
por: Berndsen, Robert H., et al.
Publicado: (2017)

Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression
por: Berndsen, Robert H., et al.
Publicado: (2019)

A streamlined search technology for identification of synergistic drug combinations
por: Weiss, Andrea, et al.
Publicado: (2015)

Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines
por: Glykofridis, Iris E., et al.
Publicado: (2022)

INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
por: Beekhof, Robin, et al.
Publicado: (2019)

Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate
por: Rolfs, Frank, et al.
Publicado: (2021)

Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies
por: Cordo’, Valentina, et al.
Publicado: (2022)

Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
por: Nazarov, Alexey A., et al.
Publicado: (2013)

In vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia
por: Clavel, Catherine M., et al.
Publicado: (2015)

Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3–Linked Sialic Acid Ligand Binding
por: Li, Rui-Jún Eveline, et al.
Publicado: (2021)

Re-assessment of the high-grade serous ovarian cancer phosphoproteome – Identification of kinase candidates in TCGA tumors for future clinical intervention
por: Rolfs, Frank, et al.
Publicado: (2019)

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2022)

The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)

Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors
por: Cucchi, David G. J., et al.
Publicado: (2021)

Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering
por: Weiss, Andrea, et al.
Publicado: (2019)

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2022)

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition
por: Nowak-Sliwinska, P, et al.
Publicado: (2015)

Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells
por: Rausch, Magdalena, et al.
Publicado: (2021)

Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
por: Labots, Mariette, et al.
Publicado: (2020)

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
por: Rausch, Magdalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mefoubk32o7abf35o890m4jfa8